Stifel analyst Dae Gon Ha reiterated a Buy rating on Ultragenyx Pharma (NASDAQ: RARE), following the company's report of GTX-102 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE